Skip to main content
Virtual RealityExercise and fitnessDigital healthHealthy volunteersHealthmaxxingDevice

What this study is

Postural instability is a common symptom of vestibular dysfunction that impacts a person's day-to-day activities. Vestibular rehabilitation is effective in decreasing dizziness, visual symptoms and improving postural control through several mechanisms including sensory reweighting. As part of the sensory reweighting mechanisms, vestibular activation training with headshake activities influence vestibular reflexes. However, combining challenging vestibular and postural tasks to facilitate more effective rehabilitation outcomes is under-utilized. The novel concurrent headshake and weight shift training (Concurrent HS-WST) is purported to train the vestibular system to directly impact the postural control system simultaneously and engage sensory reweighting to improve balance. Young healthy participants will perform the training by donning a virtual reality headset with an overhead harness on and a spotter present to prevent any falls. The investigators propose that this training strategy would show improved outcomes over traditional training methods by improving vestibular-ocular reflex (VOR) gains, eye movement variability, sensory reweighting and promoting postural balance. The findings of this study may guide clinicians to develop rehabilitation methods for vestibular postural control in neurological populations with vestibular and/or sensorimotor control impairment.

What's being tested

  • Vestibular training using VR followed by Control

    Intervention · DEVICE

    A cross-over design will be used with group one receiving the training intervention for 6 days, a 4-day washout period, and a 6-day no-training period.

  • Control followed by Vestibular training using VR

    Intervention · DEVICE

    Group two will follow the reverse sequence.

Study details

Sponsor
Clarkson University
Conditions
Virtual Reality · Vestibular Training · Balance Assessment
Enrolling
30 people
Starts
2022-10-03
Est. completion
2025-08-30
Design
Open-label, randomized, crossover
Record
View on ClinicalTrials.gov ↗